Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value
Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.
CertaraAugust 21, 2025
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management
Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…
CertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial
Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…
CertaraAugust 13, 2025
Certara Announces D360 25.5 Release, Featuring Dynamic Data Subsets and Enhanced Analytics
D360 v25.5 allows scientists to divide up a dataset into series of compounds & perform…
CertaraAugust 7, 2025
